Topic resource collection
Approved comparison material connected to this topic.
774 resourcesRead both sides
BPC-157 VEGF upregulation, angiogenesis, FAK-paxillin activation Proliferative (weeks 2–8) Rat MCL and Achilles models show 30–40% faster healing, improved tensile strength 10 mcg/kg daily, local or systemic Strongest preclinical…
The table below compares the three peptides with the strongest published evidence for NASH-specific mechanisms. Including their primary pathway of action, documented effects in preclinical models, typical dosing ranges, and the e…
Not all peptides that claim to support DNA integrity work the same way. Some activate repair enzymes directly. Others reduce the damage load by suppressing upstream stressors. Others still enhance immune clearance of cells that h…
Before selecting a peptide protocol, understand that subcutaneous fat loss depends on sustained caloric deficit. Peptides enhance the process but don't replace it. The table below ranks compounds by clinical evidence for total bo…
Thymalin Thymus / Immune System Restores thymic peptide output; normalizes T-cell differentiation and reduces systemic inflammation Preclinical + observational human studies Subcutaneous injection Requires sustained use (14–21 da…
This table compares the peptides with actual PE-related clinical data. | Peptide | Primary Mechanism | Evidence Quality | Typical IELT Extension (Mean) | Onset Time | Known Limitations | Professional Assessment ||—|—|—|—|—|—|| Me…
Thymalin Thymic hormone restoration → enhanced pineal melatonin synthesis 5–10 mg SC every 48–72 hours for 10–20 doses 10–14 days for rhythm changes; peaks at 4–6 weeks Age-related phase shifts, ASPS in older adults, immune-relat…
The table below compares the three primary peptide approaches for growth hormone stimulation and downstream testosterone support. Categorized by mechanism, dosing complexity, and realistic timeline. GHRH Analogs (CJC-1295 with DA…
The evidence base for peptide-assisted bone healing is uneven across compounds. Some peptides have been studied in controlled human trials; most remain confined to animal models. The table below compares mechanism, research depth…
Peptide Type Generic peptide blend, unspecified concentration Palmitoyl pentapeptide-4 or GHK-Cu, top 3 ingredients Research-grade peptides, verified molecular weight and purity Palmitoyl pentapeptide-4 and GHK-Cu demonstrate str…
Most peptide hair formulations make claims grounded in isolated in vitro data. Cellular activity in a petri dish. Without corresponding human efficacy trials. Our experience reviewing peptide research across dermatology and regen…
Every peptide mentioned here is available as a research-grade compound through Real Peptides' full peptide collection. We mean this sincerely: the purity and sequencing accuracy matter more in cessation protocols than in almost a…
Peptides are most plausible for subacute or chronic sciatica (lasting 6–12 weeks or longer) where conservative treatment has stalled. If your sciatica resolved 80% in the first month with physical therapy and NSAIDs, adding pepti…
Before initiating any peptide protocol, understanding mechanism-specific differences determines which compound addresses your research question. Thymosin Alpha-1 Treg differentiation, IL-2R upregulation 1.6mg twice weekly ~2 hour…
This table compares three peptide protocols commonly used in chronic pain research models, showing dosing, administration frequency, and primary mechanisms. BPC-157 250–500mcg Daily Reduces inflammatory cytokines (TNF-α, IL-1β), …
CJC-1295 + Ipamorelin GH secretagogue (GHRH analog + ghrelin mimetic) Phase 2 trials showing 4.2% FFM increase, 7.8% VAT reduction over 12 weeks 100–300mcg ipamorelin + 100–200mcg CJC-1295, 2–3× weekly Mild: injection-site reacti…
FOXO4-DRI Disrupts FOXO4-p53 interaction, restoring p53-mediated apoptosis in senescent cells High. 70% senescent cell death vs <5% in proliferating cells (2017 Cell study) Strong. Phase 1 human data published 2020 7–14 days for …
Before selecting a peptide for oxidative stress research, understand that each compound operates through distinct mechanisms. There is no universal 'best' peptide, only the most appropriate peptide for the specific oxidative stre…
BPC-157 VEGF upregulation, collagen deposition, FAK-paxillin pathway modulation 10 mcg/kg daily (rodent studies) 28 days refrigerated; degrades 40% in 7 days at room temp No human pharmacokinetic data; subcutaneous bioavailabilit…
BPC-157 VEGF upregulation, FAK-paxillin pathway activation All phases (acute through remodelling) 250–500 mcg SC twice daily Moderate (animal models, limited human trials) Strongest evidence for angiogenesis and collagen organisa…